Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/30/2025

Oral Midazolam Syrup Dosing Guidelines

Age-Specific Dosing Recommendations

  • For pediatric sedation and anxiolysis, administer 0.5 mg/kg of oral midazolam syrup (maximum 20 mg), which provides optimal efficacy with acceptable safety in children aged 6 months to 16 years 1
  • The American Academy of Pediatrics notes that younger children often need higher weight-based doses to achieve satisfactory anxiolysis 1
  • Standard dose for children under 6 years is 0.5-1.0 mg/kg orally (maximum 20 mg) 1
  • Standard dose for children 6 years and older is 0.25-0.5 mg/kg orally (maximum 20 mg) 1

Safety Considerations

  • Continuous pulse oximetry is mandatory regardless of dose 1
  • Be prepared to provide respiratory support, as apnea can occur up to 30 minutes after administration 2
  • Risk of respiratory depression increases when combined with opioids—dose reduction required 2

Special Populations Requiring Dose Reduction

  • Elderly patients and those with hepatic/renal impairment should reduce dose by 20% or more 2
  • Patients on concurrent CNS depressants or opioids should reduce midazolam dose due to synergistic effects 2
  • Patients using H2-receptor antagonists may require dose reduction since bioavailability increases by 30% 2